The role of nafamostat mesylate anticoagulation in continuous kidney replacement therapy for critically ill patients with bleeding tendencies: a retrospective study on patient outcomes and safety

• Κύριοι συγγραφείς: Taeil Kim (Συγγραφέας), Dong Eon Kim (Συγγραφέας), Eun Mi Jo (Συγγραφέας), Yeji Lee (Συγγραφέας), Da Woon Kim (Συγγραφέας), Hyo Jin Kim (Συγγραφέας), Eun Young Seong (Συγγραφέας), Sang Heon Song (Συγγραφέας), Harin Rhee (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: The Korean Society of Nephrology, 2024-07-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background Continuous kidney replacement therapy (CKRT) is crucial in the management of acute kidney injury in intensive care units (ICUs). Nonetheless, the optimal anticoagulation strategy for patients with bleeding tendencies remains debated. This study aimed to evaluate patient outcomes and safet...